Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. - Wikidata - awgldk - TriplyDB

Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.

Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.

http://www.wikidata.org/entity/Q40456443

about

Current management and perspectives for HCV recurrence after liver transplantation Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review Impact of new treatment options for hepatitis C virus infection in liver transplantation Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation Hepatitis C: New challenges in liver transplantation Challenges of recurrent hepatitis C in the liver transplant patient Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation Thrombocytopenia, splenomegaly, and portal blood flow in patients who have undergone liver transplantation for cirrhosis.Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations.Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.Treatment of hepatitis C virus infection Management of recurrent hepatitis C following liver transplantation.Antiviral treatment for hepatitis C virus infection after liver transplantation.Clearance of hepatitis C virus after living-donor liver transplantation in spite of residual viremia on end date of interferon therapy before transplantation.Management of recurrent hepatitis C virus after liver transplantation.Major challenges limiting liver transplantation in the United States.Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents?Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?Prevention of hepatitis C recurrence after liver transplantation: An update.Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1.Management of hepatitis C in liver transplant recipients.Developments in clinical islet, liver thoracic, kidney and pancreas transplantation in the last 5 years.Living-donor liver transplantation and hepatitis C Hepatitis C virus re-infection: new perspectives.Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.Therapeutic management of recurrent hepatitis C after liver transplantation.Antiviral therapy: chronic hepatitis C.New perspectives for preventing hepatitis C virus liver graft infection.SASLT practice guidelines: management of hepatitis C virus infection.PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.Hepatitis C virus treatment pre- and post-liver transplantation.Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.Treatment of hepatitis C virus infection in adults and children: updated Swedish consensus recommendations.Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy.Hepatitis B and C in liver transplantation: new strategies to combat the enemies.Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients.

P2860

Q22299427-0758A835-308E-4E97-96F5-8FD61206DCD8 Q24202008-DECD6426-26EE-450B-9DE1-1AAC4880020A Q24235577-0B18AF4A-8D69-4165-933E-E2587340EBFE Q26781331-A1A424A0-A91C-4BDB-9B34-32AE0D4080EE Q26781741-743A635B-E634-4D73-BC32-807A4D839058 Q26782017-F7104910-67F5-451F-8DB2-E92D61AEEEC3 Q26864647-BF09805D-6600-4F80-8A35-434033C66FC1 Q26999368-589BAC55-6FFC-4B56-8C59-8B5005064DE1 Q27011871-2A12F400-4467-4F55-B7A0-B2B2575C4192 Q28076406-48809E96-FD58-4D38-A1D1-B74727756E32 Q33397681-2BA72A7D-8EDC-4BA8-97F5-CA6C88750D25 Q34087387-B9384136-1962-427F-81A4-BD36B32534CD Q34093754-6669C12B-B27A-461A-AECA-11D05969365D Q34099424-88FD5E8A-6885-4CDA-A836-9CD9EBC5F50B Q34298333-33D359FA-F9AA-49A9-9231-0BCE71CA9291 Q34340293-A78994AE-F785-4059-A621-101BE25FD91C Q34382172-2AFB621E-0BEF-4802-9EC4-B94E74FE78E6 Q34589655-55E65648-E63A-4A0F-A167-5FB19B13817C Q35194675-846DE233-F97F-4B42-85F4-8ADFF59BE8CC Q35214724-AEDA2F3D-3D06-4A68-9A00-97CC538F6F6A Q35790393-FCED630B-0EBA-4357-9BD9-78AD46944F33 Q36220172-2CC6685D-5F9A-4C90-8FB7-269F4025BFA1 Q36241697-220EE5DC-97DA-4200-96F6-E0A8F3F6AA8D Q36382719-E200D4CF-776E-4AEE-9D85-ED35E0C491C2 Q36392142-F7494442-5D9F-420D-BFE4-1A4D827FD19F Q36505718-9807FCAD-31B3-4241-A7F0-85B1F1D63CA1 Q36587253-899F9F46-C046-4CC9-83E8-5D7E39A76B7F Q36652081-A27F98D3-1F15-400B-B8E0-1DA2E7D36A0B Q36655931-30FE01CA-B576-4C53-8D92-0B4F33B8065F Q36758660-07A14525-99FF-462F-AD30-DF37BEDBE2DF Q36980750-B0C983E2-942A-4326-80D4-A4710EB5219E Q37015805-409E5E7D-78A8-4A45-A53E-002F7CA6FDE5 Q37019765-82BD0D4D-E89C-473E-93A7-88BB2DB06A20 Q37077437-6FD4A687-DECA-45FB-9378-D5C01ADC01F1 Q37972771-E810E005-DC15-4F72-8B5D-32B385829F00 Q37973516-556AA40C-61EB-45F9-A673-F0ADE78CF03E Q38002889-0A1A3A87-7774-455B-981A-55809F8EAAD8 Q38062943-CF937462-B886-49EE-A698-74709B291814 Q38067343-5DB7BDA4-57D5-44C1-B440-57B80A547D8C Q38083754-4368370D-7FDB-4B86-B0B4-340208B9DB09

P2860

Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.

http://www.wikidata.org/entity/Q40456443

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Applicability, tolerability an ...... ergoing liver transplantation.

@en

type

label

Applicability, tolerability an ...... ergoing liver transplantation.

@en

prefLabel

Applicability, tolerability an ...... ergoing liver transplantation.

@en

P1433

Q40456443-0397D045-A29F-4351-B9BF-A25B93610B8D

P1476

Q40456443-27129D53-8BE6-482D-8659-9960362B3E53

P2093

Q40456443-4641191E-4DBE-448F-A917-C0A3F0F83638

Q40456443-4A650122-7526-4852-B954-F92916217295

Q40456443-4FB09951-6F9A-4B06-8FC0-203D82AA8471

Q40456443-92148F04-0027-4D29-8310-D2B3C04709ED

Q40456443-A330B676-1BAB-463A-A0BC-683B015F3BB3

Q40456443-B7883C2C-1F0A-45C4-AA01-77CD71162D25

Q40456443-F5644B59-2D08-4236-B46F-129E09A8E1EF

P2860

Q40456443-1705FD6B-B556-48F3-B055-AF5686F107FD

Q40456443-27E60A32-D0D4-46D2-9963-D8F510176237

Q40456443-296900D1-CB39-410C-934D-718CD6926CFF

Q40456443-2B9DC42C-9DDC-4514-B564-BBF2713E12F5

Q40456443-2D473CF2-0AE5-4B7A-8207-B0825E50A348

Q40456443-3371579C-23EE-4581-8DCE-2531E449B059

Q40456443-3BA4B146-A530-4F70-BF13-ED106CBB9D52

Q40456443-5073AC51-FF1E-4950-8B62-A2D621EAE171

Q40456443-8267C63D-850E-4A41-A016-77678C26813D

Q40456443-A6AA53C0-C2DD-4DA7-9571-087DF94FC91B

P304

Q40456443-AD5C74F7-D6B6-41C8-80BC-5C74E36455CA

P31

Q40456443-E77C4142-EA25-4291-AF15-E38E23F7EB40

P356

Q40456443-61F6D8E0-692B-40EC-B954-9CF0C1167DA6

P407

Q40456443-39204D2A-105C-4B41-8827-83A5FC4AA8BB

P433

Q40456443-4A555011-1C77-42F9-A1BD-861CCCF32E02

P478

Q40456443-0505AE76-0E9F-4531-8EBB-C768E1B75E7E

P577

Q40456443-AF61D091-5027-4294-B50F-71342BF7C9A7

P5875

Q40456443-02DBBA5A-DD51-4434-8E86-CF896B37F051

P698

Q40456443-D406602D-AD9D-4129-8560-7E278EA93931

P921

Q40456443-F78784C3-980A-42AE-B647-6178FB517BBA

P356

J.1600-6143.2004.00648.X

P1433

American Journal of Transplantation

P1476

Applicability, tolerability an ...... ergoing liver transplantation.

@en

P2093

Amandeep K Shergill

http://www.w3.org/2001/XMLSchema#string

John P Roberts

http://www.w3.org/2001/XMLSchema#string

Kathy Bollinger

http://www.w3.org/2001/XMLSchema#string

Mandana Khalili

http://www.w3.org/2001/XMLSchema#string

Nancy A Ascher

http://www.w3.org/2001/XMLSchema#string

Norah A Terrault

http://www.w3.org/2001/XMLSchema#string

Stephanie Straley

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation.

Pharmacokinetics of natural human IFN-alpha in hemodialysis patients.

HCV-related fibrosis progression following liver transplantation: increase in recent years.

Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa.

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study.

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

Long-term outcome of hepatitis C infection after liver transplantation.

P304

118-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-6143.2004.00648.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8093957

http://www.w3.org/2001/XMLSchema#string

P698

15636619

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation